Remedly
Future-proofing the healthcare industry with innovative solutions that transform practices and improve patient care
Future-proofing the healthcare industry with innovative solutions that transform practices and improve patient care
Remedly is a B2B enterprise software startup focused on the health care industry. Founded in 2014, it recently received a $250.00K Series A investment on 03 January 2023 from Newchip Accelerator. This investment marks a significant step for Remedly in advancing its mission to revolutionize health care through innovative enterprise software solutions. The backing of Newchip Accelerator not only provides vital funding but also validates Remedly's potential to disrupt the health care technology landscape. With this investment, Remedly aims to further develop its products and expand its reach within the health care sector, positioning itself as a key player in the B2B enterprise software space.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $250.00K | 1 | Newchip Accelerator | 03 Jan 2023 |
| Venture Round | $985.00K | - | 20 Oct 2020 | |
| Series A | $4.72M | 3 |
|
18 Jul 2018 |
| Seed Round | $2.75M | 2 |
|
10 Mar 2017 |
| Convertible Note | Unknown | 1 | TA Capital | 30 Sep 2015 |
No recent news or press coverage available for Remedly.
We care about your data, and we'd love to use cookies make your experience better.
